跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 718 条关于
“WRN helicase”
全部
718
临床试验
289
药物
267
机构
9
资讯
153
去年
Novartis' Oral WRN Helicase Inhibitor HRO761 Targets MSI-High and dMMR Tumors
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
10个月前
WRN Inhibitors Enter Clinical Development Phase as Precision Oncology Market Expands
去年
IDEAYA's WRN Inhibitor IDE275 Shows Promise for MSI-H Cancers, Featured in AACR 2025 Oral Presentation
9个月前
Nimbus Therapeutics Completes Dose Escalation for Novel WRN Inhibitor NDI-219216 in MSI-H Tumors
8个月前
Eikon Therapeutics Files for $100 Million IPO to Advance Late-Stage Cancer Pipeline
去年
IDEAYA Biosciences' Werner Helicase Inhibitor IDE275 Cleared for Phase 1 Trial in MSI-High Solid Tumors
去年
Nimbus Therapeutics Advances Oncology Pipeline with WRN Inhibitor NDI-219216
去年
Nimbus Therapeutics Initiates First-in-Human Trial of NDI-219216 for MSI-H Tumors Resistant to Standard Therapies
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
第 1 页,共 16 页
上一页
下一页